Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.53 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1862223 | 1.00 | HCAR2 (0.69) | HCAR2LMNAABCG2SMN1; SMN2MAPT | |
| Acetone SCHEMBL8093753 | 0.98 | HCAR2 (0.67) | HCAR2LMNAABCG2SMN1; SMN2MAPT | |
| Acetone SCHEMBL8093756 | 0.98 | HCAR2 (0.67) | HCAR2LMNAABCG2SMN1; SMN2MAPT | |
| SCHEMBL5598741 | 0.83 | HCAR2 (0.74) | HCAR2LMNAABCG2SMN1; SMN2MAPT | |
| SCHEMBL5598744 | 0.83 | HCAR2 (0.74) | HCAR2LMNAABCG2SMN1; SMN2MAPT | |
| SCHEMBL143282 | 0.82 | HCAR2 (1.00) | HCAR2LMNAABCG2SMN1; SMN2MAPT | |
| SCHEMBL600082 | 0.82 | HCAR2 (1.00) | HCAR2LMNAABCG2SMN1; SMN2MAPT | |
| SCHEMBL4197243 | 0.82 | HCAR2 (0.71) | HCAR2LMNAABCG2SMN1; SMN2MAPT | |
| SCHEMBL1086015 | 0.82 | HCAR2 (0.71) | HCAR2LMNAABCG2SMN1; SMN2MAPT | |
| SCHEMBL24728234 | 0.80 | HCAR2 (0.58) | HCAR2LMNAABCG2SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104860854-A | Method for synthesizing beta-thiocarbonyl compound by taking Bunte salt as sulfur source | UNIV NANJING SCIENCE & TECH | 2015-08-26 | — | — | CN | claimed |
| EP-4727923-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | University of Georgia Research Foundation, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260098012-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | UNIV GEORGIA (US) | 2026-04-09 | — | — | US | disclosed |
| US-12519071-B2 | Structure containing Sn layer or Sn alloy layer | ISHIHARA CHEMICAL CO., LTD. (JP) | 2026-01-06 | — | — | US | disclosed |
| EP-3238861-B1 | SOLDER MATERIAL, SOLDER PASTE, FOAM SOLDER, FLUX COATING MATERIAL | SENJU METAL INDUSTRY CO (JP) | 2025-08-27 | — | — | EP | disclosed |
| US-12388035-B2 | Structure comprising under barrier metal and solder layer, and method for producing structure | ISHIHARA CHEMICAL CO., LTD. (JP) | 2025-08-12 | — | — | US | disclosed |
| WO-2024258904-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2024-12-19 | — | — | WO | disclosed |
| US-20240258255-A1 | STRUCTURE COMPRISING UNDER BARRIER METAL AND SOLDER LAYER, AND METHOD FOR PRODUCING STRUCTURE | ISHIHARA CHEMICAL CO., LTD. (JP) | 2024-08-01 | — | — | US | disclosed |
| EP-4350748-A1 | STRUCTURE COMPRISING UNDER BARRIER METAL AND SOLDER LAYER, AND METHOD FOR PRODUCING STRUCTURE | Ishihara Chemical Co., Ltd (JP) | 2024-04-10 | — | — | EP | disclosed |
| US-11939691-B2 | Tin or tin alloy electroplating bath, and electronic component having electrodeposit formed thereon using the plating bath | ISHIHARA CHEMICAL CO., LTD. (JP) | 2024-03-26 | — | — | US | disclosed |
| US-7326423-B2 | Copolymerizable azo compounds and articles containing them | ADVANCED MEDICAL OPTICS, INC. (US) | 2008-02-05 | — | — | US | disclosed |
| US-7179308-B2 | Ethylenically-unsaturated blue anthraquinone dyes | EASTMAN CHEMICAL COMPANY (US) | 2007-02-20 | — | — | US | disclosed |
| US-7172634-B2 | Ethylenically-unsaturated blue anthraquinone dyes | EASTMAN CHEMICAL COMPANY (US) | 2007-02-06 | — | — | US | disclosed |
| EP-1026151-B1 | Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides and insecticides | DOW AGROSCIENCES LLC (US) | 2005-03-16 | — | — | EP | disclosed |
| WO-2004018462-A1 | QUINAZOLINONE DERIVATIVES | CELLTECH R & D LIMITED (GB) | 2004-03-04 | — | — | WO | disclosed |
| EP-1026151-A1 | Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides and insecticides | ROHM AND HAAS COMPANY (US) | 2000-08-09 | — | — | EP | disclosed |
| US-6063956-A | APPLYING FUNGICIDE OR INSECTICIDE TO THE LOCUS WHERE CONTROL IS DESIRED | ROHM AND HAAS COMPANY (US) | 2000-05-16 | — | — | US | disclosed |
| EP-0316790-B1 | RHODANINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND THEIR USE | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1993-08-11 | — | — | EP | disclosed |
| US-4897406-A | CHEMICAL MEDIATOR INHIBITORS INCLUDING LEUKOTRIENES; ANTIALLERGENS; BRONCHODILATOR AND ANTIICHEMIC AGENTS | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1990-01-30 | — | — | US | disclosed |
| EP-0316790-A1 | Rhodanine derivatives, a process for their preparation, pharmaceutical compositions and their use | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1989-05-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098012-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | CD47, SLC11A2, G6PD | HCAR2 1623/4885LMNA 297/4885ABCG2 2496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.